- Published: Friday, 24 November 2017 09:48
- Hits: 1295
This 1-year project takes advantage of data from a large longitudinal study investigating potential neurocognitive and neurobiological predictors of response to standard antidepressant treatment in MDD. The proposed project has two parts:
Part 1. Aim: To validate and implement the novel EMOTICOM test battery as a research and clinical assessment tool for affective and social cognition.
Part 2. Aim: To determine baseline differences in affective and social cognition outcomes assessed with the EMOTICOM between MDD patients and healthy individuals.